Table of Contents
Advances in Nephrology
Volume 2014, Article ID 516381, 8 pages
http://dx.doi.org/10.1155/2014/516381
Review Article

Managing End-Stage Renal Disease in Older Patients: A Single Centre Experience with Renal Transplantation in the Elderly

1Section of Nephrology, Department of Organ Transplantation, Oslo University Hospital Rikshospitalet, 0424 Oslo, Norway
2Clinic of Internal Medicine, Telemark Hospital, 3710 Skien, Norway
3Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway

Received 12 December 2013; Revised 24 February 2014; Accepted 24 February 2014; Published 25 March 2014

Academic Editor: Francois Madore

Copyright © 2014 Karsten Midtvedt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Collins, R. N. Foley, C. Herzog et al., “US renal data system 2012 annual data report,” The American Journal of Kidney Diseases, vol. 61, no. 1, supplement 1, p. A7, 2013. View at Publisher · View at Google Scholar
  2. T. Leivestad, “Annual report Norwegian renal registry 2012,” 2013, http://www.nephro.no/nnr.html.
  3. B. L. Kasiske, C. B. Cangro, S. Hariharan et al., “The evaluation of renal transplant candidates: clinical practice guidelines,” The American Journal of Transplantation, vol. 1, no. 2, pp. 5–95, 2001. View at Google Scholar · View at Scopus
  4. C. Dudley and P. Harden, Assessment of the Potential Kidney Transplant Recipient, The Renal Association, 2011, http://www.renal.org/Clinical/GuidelinesSection/AssessmentforRenalTransplantation.aspx.
  5. G. Knoll, S. Cockfield, T. Blydt-Hansen et al., “Canadian society of transplantation consensus guidelines on eligibility for kidney transplantation,” Canadian Medical Association Journal, vol. 173, no. 10, pp. S1–S25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Kontodimopoulos and D. Niakas, “An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy,” Health Policy, vol. 86, no. 1, pp. 85–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Wolfe, V. B. Ashby, E. L. Milford et al., “Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant,” The New England Journal of Medicine, vol. 341, no. 23, pp. 1725–1730, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Niakas and N. Kontodimopoulos, “Is renal transplantation the most cost-effective and preferable therapy for patients suffering from end-stage renal disease or not?” Health Policy, vol. 89, no. 3, pp. 329–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Rebollo, F. Ortega, J. M. Baltar et al., “Health related quality of life (HRQOL) of kidney transplanted patients: variables that influence it,” Clinical Transplantation, vol. 14, no. 3, pp. 199–207, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. F. E. M. Murtagh, J. E. Marsh, P. Donohoe, N. J. Ekbal, N. S. Sheerin, and F. E. Harris, “Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5,” Nephrology Dialysis Transplantation, vol. 22, no. 7, pp. 1955–1962, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. “Euorotransplant annual report 2012,” 2013, http://www.eurotransplant.nl/?id=annual_report.
  12. K. K. Stevens, Y. M. Woo, M. Clancy, J. D. McClure, J. G. Fox, and C. C. Geddes, “Deceased donor transplantation in the elderly—are we creating false hope?” Nephrology Dialysis Transplantation, vol. 26, no. 7, pp. 2382–2386, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. D. Schold, T. R. Srinivas, A. R. Sehgal, and H. U. Meier-Kriesche, “Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 7, pp. 1239–1245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Petersen, B. C. Baird, F. Shihab et al., “The impact of recipient history of cardiovascular disease on kidney transplant outcome,” ASAIO Journal, vol. 53, no. 5, pp. 601–608, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Heldal, A. Hartmann, T. Leivestad et al., “Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity,” Transplantation, vol. 87, no. 7, pp. 1045–1051, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Liu, Z. Huang, D. T. Gilbertson, R. N. Foley, and A. J. Collins, “An improved comorbidity index for outcome analyses among dialysis patients,” Kidney International, vol. 77, no. 2, pp. 141–151, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Huang, N. Poommipanit, M. S. Sampaio et al., “Intermediate-term outcomes associated with kidney transplantation in recipients 80 years and older: an analysis of the OPTN/UNOS database,” Transplantation, vol. 90, no. 9, pp. 974–979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. K. Munshi, N. Vijayakumar, N. A. Taub, H. Bhullar, T. C. N. Lo, and G. Warwick, “Outcome of renal replacement therapy in the very elderly,” Nephrology Dialysis Transplantation, vol. 16, no. 1, pp. 128–133, 2001. View at Google Scholar · View at Scopus
  19. P. S. Rao, R. M. Merion, V. B. Ashby, F. K. Port, R. A. Wolfe, and L. K. Kayler, “Renal transplantation in elderly patients older than 70 years of age: results from the scientific registry of transplant recipients,” Transplantation, vol. 83, no. 8, pp. 1069–1074, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Wu, R. Shapiro, H. Tan et al., “Kidney transplantation in elderly people: the influence of recipient comorbidity and living kidney donors,” Journal of the American Geriatrics Society, vol. 56, no. 2, pp. 231–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Heldal, T. Leivestad, A. Hartmann, M. V. Svendsen, B. H. Lien, and K. Midtvedt, “Kidney transplantation in the elderly—the Norwegian experience,” Nephrology Dialysis Transplantation, vol. 23, no. 3, pp. 1026–1031, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. G. van Manen, P. C. W. van Dijk, V. S. Stel et al., “Confounding effect of comorbidity in survival studies in patients on renal replacement therapy,” Nephrology Dialysis Transplantation, vol. 22, no. 1, pp. 187–195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Heldal, A. Hartmann, D. C. Grootendorst et al., “Benefit of kidney transplantation beyond 70 years of age,” Nephrology Dialysis Transplantation, vol. 25, no. 5, pp. 1680–1687, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Heldal, A. Hartmann, T. Leivestad, A. Foss, and K. Midtvedt, “Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium,” Nephrology Dialysis Transplantation, vol. 26, no. 8, pp. 2706–2711, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. D. McKay and J. Jameson, “Kidney transplantation and the ageing immune system,” Nature Reviews Nephrology, vol. 8, no. 12, pp. 700–708, 2012. View at Publisher · View at Google Scholar
  26. H. U. Meier-Kriesche, A. Ojo, J. Hanson et al., “Increased immunosuppressive vulnerability in elderly renal transplant recipients,” Transplantation, vol. 69, no. 5, pp. 885–889, 2000. View at Google Scholar · View at Scopus
  27. M. Badowski, C. Gurk-Turner, C. Cangro et al., “The impact of reduced immunosuppression on graft outcomes in elderly renal transplant recipients,” Clinical Transplantation, vol. 23, no. 6, pp. 930–937, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. W. de Fijter, M. J. K. Mallat, I. I. N. Doxiadis et al., “Increased immunogenicity and cause of graft loss of old donor kidneys,” Journal of the American Society of Nephrology, vol. 12, no. 7, pp. 1538–1546, 2001. View at Google Scholar · View at Scopus
  29. R. Oberhuber, X. Ge, and S. G. Tullius, “Donor age-specific injury and immune responses,” The American Journal of Transplantation, vol. 12, no. 1, pp. 38–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Pratschke, V. Merk, A. Reutzel-Selke et al., “Potent early immune response after kidney transplantation in patients of the European senior transplant program,” Transplantation, vol. 87, no. 7, pp. 992–1000, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Heldal, S. Thorarinsdottir, A. Hartmann et al., “Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study,” Transplantation Research, vol. 2, article 11, 2013. View at Publisher · View at Google Scholar
  32. D. C. Brennan, J. A. Daller, K. D. Lake, D. Cibrik, and D. Del Castillo, “Rabbit antithymocyte globulin versus basiliximab in renal transplantation,” The New England Journal of Medicine, vol. 355, no. 19, pp. 1967–1977, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. R. D. Morgan, J. M. O'Callaghan, S. R. Knight, and P. J. Morris, “Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis,” Transplantation, vol. 93, no. 12, pp. 1179–1188, 2012. View at Publisher · View at Google Scholar
  34. G. Tyden, H. Ekberg, G. Tufveson, and L. Mjornstedt, “A randomized, double-blind, placebo-controlled study of single dose rituximab as induction in renal transplantation: a 3-year follow-up,” Transplantation, vol. 94, no. 3, pp. e21–e22, 2012. View at Publisher · View at Google Scholar
  35. J. Gill, M. Sampaio, J. S. Gill et al., “Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 5, pp. 1168–1178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Falck, A. Åsberg, K. Byberg et al., “Reduced elimination of cyclosporine a in elderly (>65 years) kidney transplant recipients,” Transplantation, vol. 86, no. 10, pp. 1379–1383, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Heldal and K. Midtvedt, “Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens,” Drugs and Aging, vol. 30, no. 7, pp. 459–466, 2013. View at Publisher · View at Google Scholar
  38. M. W. van den Hoogen, A. J. Hoitsma, and L. B. Hilbrands, “Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation,” Expert Opinion on Biological Therapy, vol. 12, no. 8, pp. 1031–1042, 2012. View at Publisher · View at Google Scholar
  39. K. Midtvedt, P. Fauchald, B. Lien et al., “Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection,” Clinical Transplantation, vol. 17, no. 1, pp. 69–74, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Vincent and V. Velkoff, “The next four decades. The older population in the United States: 2010 to 2050 population estimates and projections,” US Department of Commerce Economics and Statistics Administration, 2010, http://www.census.gov/prod/2010pubs/p25-1138.pdf.
  41. M. Cooper and C. L. Forland, “The elderly as recipients of living donor kidneys, how old is too old?” Current Opinion in Organ Transplantation, vol. 16, no. 2, pp. 250–255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. F. K. Port, J. L. Bragg-Gresham, R. A. Metzger et al., “Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors,” Transplantation, vol. 74, no. 9, pp. 1281–1286, 2002. View at Google Scholar · View at Scopus
  43. C. M. Mandigers, W. de Jong, A. W. L. van den Wall Bake, and P. G. Gerlag, “Renal replacement therapy in the elderly,” Netherlands Journal of Medicine, vol. 49, no. 4, pp. 135–142, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Heldal and K. Midtvedt, “Doctor, should I remain on dialysis or accept the ECD kidney offered to me?” The American Journal of Kidney Diseases, vol. 59, no. 6, pp. 748–750, 2012. View at Google Scholar
  45. J. D. Schold, B. Kaplan, R. S. Baliga, and H. U. Meier-Kriesche, “The broad spectrum of quality in deceased donor kidneys,” The American Journal of Transplantation, vol. 5, no. 4, part 1, pp. 757–765, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Remuzzi, J. Grinyò, P. Ruggenenti et al., “Early experience with dual kidney transplantation in adults using expanded donor criteria,” Journal of the American Society of Nephrology, vol. 10, no. 12, pp. 2591–2598, 1999. View at Google Scholar · View at Scopus
  47. G. Remuzzi, P. Cravedi, A. Perna et al., “Long-term outcome of renal transplantation from older donors,” The New England Journal of Medicine, vol. 354, no. 4, pp. 343–352, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Foss, K. Heldal, H. Scott et al., “Kidneys from deceased donors more than 75 years perform acceptably after transplantation,” Transplantation, vol. 87, no. 10, pp. 1437–1441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. United Network for Organ Sharing (UNOS), UNOS, 2013, http://www.unos.org/.
  50. W. H. Lim, S. Chang, S. Chadban et al., “Donor-recipient age matching improves years of graft function in deceased-donor kidney transplantation,” Nephrology Dialysis Transplantation, vol. 25, no. 9, pp. 3082–3089, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Midtvedt, T. Namtvedt, H. Scott et al., “Single transplanted kidneys from a 90-year-old deceased donor perform acceptably at 1 year,” Transplantation Proceedings, vol. 43, no. 5, pp. 2107–2109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. R. D. Hays, J. D. Kallich, D. L. Mapes, S. J. Coons, and W. B. Carter, “Development of the kidney disease quality of life (KDQOL(TM)) instrument,” Quality of Life Research, vol. 3, no. 5, pp. 329–338, 1994. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Tong, J. R. Chapman, A. Israni, E. J. Gordon, and J. C. Craig, “Qualitative research in organ transplantation: recent contributions to clinical care and policy,” The American Journal of Transplantation, vol. 13, no. 6, pp. 1390–1399, 2013. View at Publisher · View at Google Scholar
  54. K. Malterud, “Qualitative research: standards, challenges, and guidelines,” The Lancet, vol. 358, no. 9280, pp. 483–488, 2001. View at Publisher · View at Google Scholar · View at Scopus